TCIM
ACOR

TIAA CREF Investment Management’s Acorda Therapeutics ACOR Stock Holding History

TIAA CREF Investment Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.69M Sell
1,686
-43
-2% -$77.5K ﹤0.01% 1828
2018
Q4 		$3.23M Sell
1,729
-122
-7% -$265K ﹤0.01% 1654
2018
Q3 		$4.36M Buy
1,851
+418
+29% +$1.29M ﹤0.01% 1648
2018
Q2 		$4.94M Buy
1,433
+288
+25% +$882K ﹤0.01% 1606
2018
Q1 		$3.25M Buy
1,145
+24
+2% +$71.9K ﹤0.01% 1835
2017
Q4 		$2.88M Sell
1,121
-601
-35% -$1.71M ﹤0.01% 1936
2017
Q3 		$4.89M Sell
1,722
-131
-7% -$345K ﹤0.01% 1640
2017
Q2 		$4.38M Buy
1,853
+651
+54% +$1.29M ﹤0.01% 1679
2017
Q1 		$3.03M Sell
1,202
-65
-5% -$187K ﹤0.01% 1894
2016
Q4 		$2.86M Sell
1,267
-64
-5% -$152K ﹤0.01% 1981
2016
Q3 		$3.34K Sell
1,331
-112
-8% -$334K ﹤0.01% 1866
2016
Q2 		$4.42M Buy
1,443
+68
+5% +$221K ﹤0.01% 1630
2016
Q1 		$4.36M Sell
1,375
-35
-2% -$145K ﹤0.01% 1595
2015
Q4 		$7.24M Sell
1,410
-38
-3% -$166K 0.01% 1291
2015
Q3 		$4.61M Sell
1,448
-152
-10% -$589K ﹤0.01% 1586
2015
Q2 		$6.4M Sell
1,600
-170
-10% -$657K ﹤0.01% 1492
2015
Q1 		$7.07M Sell
1,770
-28
-2% -$128K ﹤0.01% 1391
2014
Q4 		$8.82M Sell
1,798
-25
-1% -$107K 0.01% 1203
2014
Q3 		$7.41M Sell
1,823
-28
-2% -$105K 0.01% 1315
2014
Q2 		$7.49M Buy
1,851
+46
+3% +$188K 0.01% 1383
2014
Q1 		$8.21M Sell
1,805
-32
-2% -$129K 0.01% 1257
2013
Q4 		$6.44M Sell
1,837
-235
-11% -$916K ﹤0.01% 1448
2013
Q3 		$8.52M Sell
2,072
-31
-1% -$134K 0.01% 1195
2013
Q2 		$8.32M Buy
+2,103
New +$8.66M 0.01% 1163

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

TIAA CREF Investment Management's ACOR Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Acorda Therapeutics (ACOR) stake by 2.5% in Q1 2019, selling an estimated $77.5K and leaving 1,686 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1828.

TIAA CREF Investment Management first reported a position in ACOR in Q2 2013 and has held it in 24 quarters since. The position peaked at $8.82M in Q4 2014. 184 funds tracked by Wall St. Rank hold ACOR as of Q1 2019.

  • TIAA CREF Investment Management held 1,686 shares of Acorda Therapeutics worth $2.69M as of Q1 2019.
  • TIAA CREF Investment Management sold 43 Acorda Therapeutics shares in Q1 2019, an estimated $77.5K.
  • Acorda Therapeutics made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1828 holding.
  • TIAA CREF Investment Management first reported a position in Acorda Therapeutics in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Acorda Therapeutics position peaked at $8.82M in Q4 2014.
  • 184 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.